Medicare Advantage Medical Policy Updates
Effective August 1, 2026
Blue Cross and Blue Shield of Nebraska is proud to work with our provider network to serve your patients, our members. We are updating several medical policies. Please review the changes and effective dates outlined here:
New Medical Policies for Medicare Advantage
Medical Policy Name: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancer (NMSC)
Effective Date: 08/01/2026
Preauthorization Required: Yes
Codes: 77336, 77370, 77436, 77437, 77439
Policy Statement:
We will utilize LCD
L40193 - Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
L40193 - Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
Medical Policy Name: Cardiac Contractility Modulation (CCM) for Heart Failure (HF)
Effective Date: 08/01/2026
Preauthorization Required: Yes
Codes: 0408T, 0409T, 0410T, 0411T, 0412T, 0413T, 0414T, 0415T, 0416T, 0417T, 0418T
Policy Statement:
We will utilize NCD
NCD - Cardiac Contractility Modulation (CCM) for Heart Failure (HF) (20.39)
Medical Policy Name: Renal Denervation (RDN) for Uncontrolled Hypertension
Effective Date: 08/01/2026
Preauthorization Required: Yes
Codes: 0338T, 0339T, C1735, C1736
Policy Statement:
We will utilize NCD
NCD - Renal Denervation (RDN) for Uncontrolled Hypertension (20.40)
NCD - Renal Denervation (RDN) for Uncontrolled Hypertension (20.40)